Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 1/20 | 0.56 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.56 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.56 |
| ▸ | CA1 | P00915 | 2/20 | 0.51 |
| ▸ | CA2 | P00918 | 2/20 | 0.51 |
| ▸ | NPC1 | O15118 | 4/20 | 0.50 |
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.50 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | CRHBP | P24387 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.49 |
| ▸ | APEX1 | P27695 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18659048 | 0.90 | CA1 (0.56) | HDAC3HDAC1HDAC2CA1CA2 | |
| SCHEMBL27062468 | 0.86 | HDAC3 (0.53) | HDAC3HDAC1HDAC2CA1CA2 | |
| SCHEMBL25767389 | 0.83 | CA1 (0.59) | HDAC3HDAC1HDAC2CA1CA2 | |
| SCHEMBL688943 | 0.82 | MAPT (0.47) | HDAC3HDAC1HDAC2NPC1RAB9A | |
| SCHEMBL21335533 | 0.81 | MAPT (0.49) | HDAC3HDAC1HDAC2CA2NPC1 | |
| SCHEMBL12897088 | 0.80 | CA1 (0.59) | CA1CA2NPC1RAB9ATAS1R3 | |
| SCHEMBL1879426 | 0.79 | POLB (0.66) | CA1CA2NPC1RAB9ATAS1R3 | |
| SCHEMBL1877455 | 0.79 | EPHX2 (0.48) | HDAC3HDAC1HDAC2MEN1EPHX2 | |
| SCHEMBL19884360 | 0.78 | CA1 (0.53) | HDAC3HDAC1HDAC2CA1CA2 | |
| SCHEMBL11756018 | 0.78 | NPC1 (0.56) | CA1CA2NPC1RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7939688-B2 | Reacting N-alkylcarboxamides or ammonium salts of carboxylic acids in the presence of alkylamines or ammonium salts of in presence of 2,4,6-substituted 1,3,5,2,4,6-trioxatriphosphinane 2,4,6-trioxide and/or a base | ARCHIMICA GMBH (DE) | 2011-05-10 | — | — | US | disclosed |
| US-20080242884-A1 | Process for Preparing Nitriles by Elimination Reactions | EUTICALS GMBH (DE) | 2008-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080242884-A1 | Process for Preparing Nitriles by Elimination Reactions | CBR1, CBR3, PHOSPHO1 | HDAC3 1551/4885HDAC1 2628/4885HDAC2 2791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.